Employees Retirement System of Texas maintained its stake in NxStage Medical, Inc. (NASDAQ:NXTM) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 43,000 shares of the medical device company’s stock at the close of the 2nd quarter. Employees Retirement System of Texas owned about 0.07% of NxStage Medical worth $1,078,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. FMR LLC increased its holdings in NxStage Medical by 31.8% in the 2nd quarter. FMR LLC now owns 9,860,278 shares of the medical device company’s stock valued at $247,197,000 after acquiring an additional 2,378,077 shares during the last quarter. Vanguard Group Inc. increased its holdings in NxStage Medical by 8.5% in the 1st quarter. Vanguard Group Inc. now owns 5,273,762 shares of the medical device company’s stock valued at $141,495,000 after acquiring an additional 412,233 shares during the last quarter. BlackRock Inc. increased its holdings in NxStage Medical by 38,360.4% in the 1st quarter. BlackRock Inc. now owns 4,413,326 shares of the medical device company’s stock valued at $118,408,000 after acquiring an additional 4,401,851 shares during the last quarter. Eagle Asset Management Inc. increased its holdings in NxStage Medical by 26.6% in the 2nd quarter. Eagle Asset Management Inc. now owns 2,573,603 shares of the medical device company’s stock valued at $64,520,000 after acquiring an additional 540,103 shares during the last quarter. Finally, William Blair Investment Management LLC increased its holdings in NxStage Medical by 491.6% in the 2nd quarter. William Blair Investment Management LLC now owns 1,959,318 shares of the medical device company’s stock valued at $49,120,000 after acquiring an additional 1,628,114 shares during the last quarter. Institutional investors own 92.66% of the company’s stock.

NXTM has been the topic of a number of research reports. Craig Hallum downgraded shares of NxStage Medical from a “buy” rating to a “hold” rating in a report on Monday, August 7th. Stephens downgraded shares of NxStage Medical from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $33.00 to $30.00 in a report on Wednesday, August 9th. BidaskClub upgraded shares of NxStage Medical from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Jefferies Group LLC downgraded shares of NxStage Medical from a “buy” rating to a “hold” rating and reduced their target price for the stock from $33.00 to $30.00 in a report on Tuesday, August 8th. Finally, Zacks Investment Research downgraded shares of NxStage Medical from a “buy” rating to a “hold” rating in a report on Friday, August 11th. Two investment analysts have rated the stock with a sell rating and eight have assigned a hold rating to the company’s stock. NxStage Medical currently has a consensus rating of “Hold” and a consensus price target of $30.25.

WARNING: “Employees Retirement System of Texas Has $1,078,000 Stake in NxStage Medical, Inc. (NXTM)” was published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/10/16/employees-retirement-system-of-texas-has-1078000-stake-in-nxstage-medical-inc-nxtm.html.

NxStage Medical, Inc. (NASDAQ NXTM) opened at 27.59 on Monday. The company’s market capitalization is $1.82 billion. NxStage Medical, Inc. has a one year low of $20.45 and a one year high of $30.80. The company’s 50-day moving average is $27.70 and its 200 day moving average is $25.86.

NxStage Medical (NASDAQ:NXTM) last released its quarterly earnings data on Monday, August 7th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.03). NxStage Medical had a negative net margin of 1.33% and a negative return on equity of 2.43%. The firm had revenue of $92.20 million during the quarter, compared to analysts’ expectations of $96.47 million. During the same period last year, the business earned ($0.03) earnings per share. NxStage Medical’s revenue was up .0% compared to the same quarter last year. On average, equities analysts anticipate that NxStage Medical, Inc. will post ($0.05) earnings per share for the current year.

In other NxStage Medical news, President Joseph E. Turk, Jr. sold 7,000 shares of NxStage Medical stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $22.98, for a total transaction of $160,860.00. Following the completion of the sale, the president now directly owns 82,903 shares in the company, valued at $1,905,110.94. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Joseph E. Turk, Jr. sold 24,000 shares of NxStage Medical stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $29.64, for a total transaction of $711,360.00. Following the sale, the president now owns 82,903 shares of the company’s stock, valued at $2,457,244.92. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,400 shares of company stock valued at $1,406,020. Company insiders own 4.70% of the company’s stock.

NxStage Medical Profile

NxStage Medical, Inc is a medical technology company. The Company develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. It operates through three segments. The System One segment includes revenues from the sale and rental of the System One and PureFlow SL dialysate preparation equipment and the sale of disposable products in the home and critical care markets.

Want to see what other hedge funds are holding NXTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NxStage Medical, Inc. (NASDAQ:NXTM).

Institutional Ownership by Quarter for NxStage Medical (NASDAQ:NXTM)

Receive News & Ratings for NxStage Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.